← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCCBiologicstaleMedImmune LLCPhase 2

Dabrafenib (Dabrafenib)

Melanoma · FRα

#FR#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 100%임상시험 69상태 DISCONTINUED
ADCCBiologicstaleAlliance for Clinical Trials in…releasePhase 3

Daunorubicin Hydrochloride (Daunorubicin Hydrochloride)

B Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 95%임상시험 69상태 RECRUITING
ADCCBiologicstaleMerck Sharp & Dohme LLCPhase 3

Rescue Medication (Rescue Medication)

Non Small Cell Lung Cancer · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase3#인기#항체약물접합체+3
임상시험 69상태 RECRUITING
ADCCBiologicstaleNeurocrine UK LimitedhasPhase 2

Therapeutic Hydrocortisone (Therapeutic Hydrocortisone)

Adult Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lympho… · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 6%임상시험 69상태 RECRUITING
ADCBiologicstaleBayerPhase 1

Expansion (BAY94-9343, BAY94-9343 (Expansion))

Oncology · Oncology

#Oncology#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 41.7%임상시험 68상태 ACTIVE
ADCBBiologicstalePfizerPhase 2

Binimetinib (Binimetinib)

Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 66.7%임상시험 68상태 RECRUITING
ADCBBiologicstaleUNICANCERPhase 2

Epirubicin hydrochloride (Epirubicin hydrochloride)

Breast Cancer · Breast Neoplasms

#BreastNeoplasms#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 43.3%임상시험 68상태 RECRUITING
ADCBiologicstaleAGO Research GmbHPhase 3

Pegylated Liposomal Doxorubicin Hydrochloride (Pegylated Liposomal Doxorubicin Hydrochloride)

Plasma Cell Leukemia · Recurrent Platinum-Sensitive Fallopian T

#RecurrentPlatinum-SensitiveFallo#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 64%임상시험 68상태 DISCONTINUED
ADCBiologicstaleHoffmann-La Rochevedotin (ARON-2EV study)Approved

Platinum Based Chemotherapy (Platinum Based Chemotherapy)

Non-Squamous Non-Small Cell Lung Cancer · Ovarian Cancer

#OvarianCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 66%임상시험 68상태 RECRUITING
ADCBBiologicstaleSpanish Breast Cancer Research …sPhase 2

Taxotere (Taxotere)

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 88.1%임상시험 68상태 RECRUITING
ADCBiologicstaleJanssen Research & Development,…Phase 1

Abiraterone acetate (Abiraterone acetate)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 46%임상시험 67상태 RECRUITING
ADCBiologicstaleRocheDM1 via butelase-1 with ABD…Phase 2

trastuzumab (Herceptin, Ado-trastuzumab, Ado-trastuzumab (T) emtansine (T-DM1))

Salivary Gland Cancer; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 74.1%임상시험 67상태 RECRUITING
ADCBiologicstaleHansoh BioMedical R&D Companyvedotin with pembrolizumabPhase 3

Cisplatin / carboplatin (Cisplatin / carboplatin)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 84%임상시험 67상태 RECRUITING
ADCBiologicstaleAstellasvedotin (ARON-2EV study)Phase 2

EV (Enfortumab vedotin-ejfv, Enfortumab vedotin-ejfv (EV))

Urothelial Cancer; Metastatic Urothelial Carcinoma · Urothelial Cancer

#UrothelialCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 67상태 RECRUITING
ADCBiologicstaleAstraZenecaVedotin in a Hemodialysis P…Phase 3

Gemcitabine/Carboplatin (Gemcitabine/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 69.6%임상시험 67상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 3

Pemetrexed/Carboplatin (Pemetrexed/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 87.5%임상시험 67상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 75%임상시험 66상태 RECRUITING
ADCBiologicstaleRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicstalePfizerderuxtecan improved objecti…Phase 2

Encorafenib (Encorafenib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING

5 / 52 페이지

← 이전다음 →